Page last updated: 2024-11-05

tranexamic acid and HbS Disease

tranexamic acid has been researched along with HbS Disease in 4 studies

Tranexamic Acid: Antifibrinolytic hemostatic used in severe hemorrhage.

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (75.00)24.3611
2020's1 (25.00)2.80

Authors

AuthorsStudies
Cochrane, AM1
Barton, KT1
Turner, MN1
Hulbert, ML1
Patil, V1
Ratnayake, G1
Fastovets, G1
Roter, E1
Bertolizio, G1
Collard, V1
Paquet, C1
Ingelmo, P1
Davis, NF1
McGuire, BB1
Lawlor, L1
O'Gorman, P1
O'Malley, KJ1
Fitzpatrick, JM1

Reviews

1 review available for tranexamic acid and HbS Disease

ArticleYear
Clinical 'pearls' of maternal critical care Part 2: sickle-cell disease in pregnancy.
    Current opinion in anaesthesiology, 2017, Volume: 30, Issue:3

    Topics: Acute Chest Syndrome; Anemia, Sickle Cell; Antifibrinolytic Agents; Blood Transfusion; Critical Care

2017

Other Studies

3 other studies available for tranexamic acid and HbS Disease

ArticleYear
Tranexamic acid for management of gross hematuria due to renal papillary necrosis in sickle cell disease.
    Pediatric blood & cancer, 2023, Volume: 70, Issue:10

    Topics: Anemia, Sickle Cell; Hematuria; Humans; Kidney Papillary Necrosis; Necrosis; Sickle Cell Trait; Tran

2023
Use of Tranexamic Acid in an Uncommon Triad: Hemorrhagic Stroke, Sickle Cell Disease and Severe Coagulopathy.
    Journal of pediatric hematology/oncology, 2019, Volume: 41, Issue:2

    Topics: Anemia, Sickle Cell; Blood Coagulation Disorders; Child; Female; Humans; Intracranial Hemorrhages; M

2019
Oral tranexamic acid as a novel treatment option for persistent haematuria in patients with sickle cell disease.
    Annals of hematology, 2010, Volume: 89, Issue:11

    Topics: Administration, Oral; Adolescent; Anemia, Sickle Cell; Antifibrinolytic Agents; Female; Hematuria; H

2010